1. Home
  2. BX vs SNY Comparison

BX vs SNY Comparison

Compare BX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Inc.

BX

Blackstone Inc.

N/A

Current Price

$119.48

Market Cap

94.1B

Sector

Finance

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$48.36

Market Cap

95.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BX
SNY
Founded
1985
1994
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.1B
95.7B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
BX
SNY
Price
$119.48
$48.36
Analyst Decision
Buy
Buy
Analyst Count
24
11
Target Price
★ $138.86
$54.92
AVG Volume (30 Days)
★ 4.9M
4.5M
Earning Date
10-22-2026
10-30-2026
Dividend Yield
4.00%
★ 4.99%
EPS Growth
★ 6.91
N/A
EPS
★ 3.19
N/A
Revenue
★ $14,450,265,000.00
N/A
Revenue This Year
$4.12
$3.68
Revenue Next Year
$25.39
$6.69
P/E Ratio
$37.24
★ $6.14
Revenue Growth
★ 9.22
N/A
52 Week Low
$101.73
$39.07
52 Week High
$165.14
$52.67

Technical Indicators

Market Signals
Indicator
BX
SNY
Relative Strength Index (RSI) 50.96 76.60
Support Level $119.13 $45.95
Resistance Level $120.34 $48.78
Average True Range (ATR) 3.78 0.88
MACD 0.35 0.44
Stochastic Oscillator 29.18 92.43

Price Performance

Historical Comparison
BX
SNY

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.346 trillion in total assets under management, including $961.6 billion in fee-earning assets under management, at the end of June 2026. The company operates with scale in each of its major product lines: private equity (28% of fee-earning AUM and 35% of base management fees), real estate/real assets (29% and 32%), credit and insurance (33% and 25%), and other alternatives (10% and 8%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: